Innoviva (INVA) EPS (Basic) (2010 - 2026)

Innoviva (INVA) posted EPS (Basic) of $2.52 for Q1 2026, up 1092.12% on a QoQ basis from -$0.25 in Q4 2025, and up 438.67% year-over-year from $0.47 in Q1 2025.

Innoviva (INVA) EPS (Basic) (2010 - 2026) Analysis & Trends

Innoviva's EPS (Basic) history runs 17 years deep, the most recent figure standing at $2.52 for Q1 2026.

  • Quarterly EPS (Basic) rose 438.67% year-over-year to $2.52 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.59 (up 406.96% YoY) and the FY2025 annual result came in at $4.85, up 1200.52% from the prior year.
  • EPS (Basic) was $2.52 for Q1 2026 at Innoviva, up from -$0.25 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $4.05 in Q3 2022 and bottomed at -$2.69 in Q4 2023.
  • A 5-year average of $0.45 and a median of $0.05 in 2024 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2024 — EPS (Basic) tumbled 2931.76% — and 2025, when it soared 3034.11%.
  • Innoviva's EPS (Basic) stood at -$0.23 in 2022, then sank by 1076.74% to -$2.69 in 2023, then soared by 90.78% to -$0.25 in 2024, then retreated by 2.37% to -$0.25 in 2025, then soared by 1092.12% to $2.52 in 2026.
  • Business Quant data shows INVA's EPS (Basic) at $2.52 in Q1 2026, -$0.25 in Q4 2025, and $1.55 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Innoviva 1.59 Bn 983.20 Mn 75.83 Mn 2.52

Historic Data

Download Data
DateValue
Mar 31, 2026 2.52
Dec 31, 2025 -0.25
Sep 30, 2025 1.55
Jun 30, 2025 1.01
Mar 31, 2025 -0.74
Dec 31, 2024 -0.25
Sep 30, 2024 0.05
Jun 30, 2024 -0.55
Mar 31, 2024 0.58
Dec 31, 2023 -2.69
Sep 30, 2023 1.82
Jun 30, 2023 0.02
Mar 31, 2023 0.51
Dec 31, 2022 -0.23
Sep 30, 2022 4.05
Jun 30, 2022 0.01
Mar 31, 2022 0.23
Dec 31, 2021 -0.55
Sep 30, 2021 3.68
Jun 30, 2021 1.01